biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by BigDolphin42on Sep 12, 2012 8:54am

314 Views

Post# 20351139

Banks and Investment Firms.......

....a lot of them can't buy unless stock is over $5. The stage is just being set in my opinion. I'm sitting on the edge of my seat waiting for this to explode. Because that is what it feels like it is going to do. Look at the amount of shares traded in the last 2 weeks, and tell me that it is not starting to get noticed. Patience is starting to pay off.

Bullboard Posts

The investment impact of the U.S. 25% tariff on Canadian imports